Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Equitable Holdings (EQH-PC) Other Non Operating Income (2017 - 2025)

Equitable Holdings has reported Other Non Operating Income over the past 9 years, most recently at -$363.0 million for Q4 2025.

  • Quarterly results put Other Non Operating Income at -$363.0 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was -$2.1 billion (up 10.57% YoY), and the annual figure for FY2025 was -$2.1 billion, up 19.44%.
  • Other Non Operating Income for Q4 2025 was -$363.0 million at Equitable Holdings, up from -$1.1 billion in the prior quarter.
  • Over the last five years, Other Non Operating Income for EQH-PC hit a ceiling of $1.9 billion in Q2 2022 and a floor of -$3.2 billion in Q4 2021.
  • Median Other Non Operating Income over the past 5 years was -$714.0 million (2024), compared with a mean of -$618.7 million.
  • Biggest five-year swings in Other Non Operating Income: surged 254.96% in 2022 and later plummeted 628.93% in 2023.
  • Equitable Holdings' Other Non Operating Income stood at -$3.2 billion in 2021, then skyrocketed by 59.34% to -$1.3 billion in 2022, then soared by 98.62% to -$18.0 million in 2023, then plummeted by 3866.67% to -$714.0 million in 2024, then skyrocketed by 49.16% to -$363.0 million in 2025.
  • The last three reported values for Other Non Operating Income were -$363.0 million (Q4 2025), -$1.1 billion (Q3 2025), and -$1.4 billion (Q2 2025) per Business Quant data.